S. Hirschberger

868 total citations
8 papers, 534 citations indexed

About

S. Hirschberger is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, S. Hirschberger has authored 8 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 1 paper in Pathology and Forensic Medicine. Recurrent topics in S. Hirschberger's work include Diabetes Management and Research (6 papers), Diabetes Treatment and Management (5 papers) and Pancreatic function and diabetes (4 papers). S. Hirschberger is often cited by papers focused on Diabetes Management and Research (6 papers), Diabetes Treatment and Management (5 papers) and Pancreatic function and diabetes (4 papers). S. Hirschberger collaborates with scholars based in Germany, Austria and Denmark. S. Hirschberger's co-authors include Gernot Brunner, Thomas R. Pieber, Andrea Wutte, Lutz Heinemann, Tim Heise, C. Weyer, Andrea Siebenhofer, Mette Loftager, Gerald Sendlhofer and Guenter J. Krejs and has published in prestigious journals such as Diabetes Care, Diabetic Medicine and Menopause The Journal of The North American Menopause Society.

In The Last Decade

S. Hirschberger

7 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Hirschberger Germany	7	491	261	195	64	21	8	534
James Desemone United States	7	210 0.4×	184 0.7×	160 0.8×	28 0.4×	7 0.3×	12	348
Jon C. Olson United States	4	327 0.7×	127 0.5×	134 0.7×	49 0.8×	6 0.3×	9	456
Chiara Gremizzi Italy	10	247 0.5×	371 1.4×	194 1.0×	40 0.6×	5 0.2×	15	484
A G Unnikrishnan India	9	237 0.5×	77 0.3×	61 0.3×	33 0.5×	13 0.6×	27	321
Iwona Pietrzak Poland	12	351 0.7×	331 1.3×	291 1.5×	134 2.1×	20 1.0×	44	578
Mustafa Tosur United States	11	200 0.4×	159 0.6×	201 1.0×	49 0.8×	4 0.2×	47	339
F. Defrance France	6	156 0.3×	206 0.8×	139 0.7×	43 0.7×	8 0.4×	11	278
László Gerő Hungary	8	194 0.4×	183 0.7×	141 0.7×	59 0.9×	6 0.3×	28	330
Mozhgan Dorkhan Sweden	13	164 0.3×	53 0.2×	93 0.5×	63 1.0×	61 2.9×	22	326
Soontaree Nakasatien Thailand	10	169 0.3×	56 0.2×	63 0.3×	49 0.8×	19 0.9×	42	260

Countries citing papers authored by S. Hirschberger

Since Specialization

Citations

This map shows the geographic impact of S. Hirschberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hirschberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hirschberger more than expected).

Fields of papers citing papers by S. Hirschberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Hirschberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hirschberger. The network helps show where S. Hirschberger may publish in the future.

Co-authorship network of co-authors of S. Hirschberger

This figure shows the co-authorship network connecting the top 25 collaborators of S. Hirschberger. A scholar is included among the top collaborators of S. Hirschberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Hirschberger. S. Hirschberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Rave, Klaus, et al.. (2009). Lack of effects of the β₃-adrenoreceptor agonist UL-TG 307 on insulin sensitivity and insulin secretion in Type 2 diabetic patients. Experimental and Clinical Endocrinology & Diabetes. 107(7). 442–446.

Bott, U., et al.. (2003). Effect of the rapid‐acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes. Diabetic Medicine. 20(8). 626–634. 66 indexed citations

Plank, Johannes, Andrea Wutte, Gernot Brunner, et al.. (2002). A Direct Comparison of Insulin Aspart and Insulin Lispro in Patients With Type 1 Diabetes. Diabetes Care. 25(11). 2053–2057. 115 indexed citations

Brunner, Gernot, S. Hirschberger, Gerald Sendlhofer, et al.. (2000). Post‐prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus. Diabetic Medicine. 17(5). 371–375. 76 indexed citations

Brunner, Gernot, Gerald Sendlhofer, Andrea Wutte, et al.. (2000). Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans. Experimental and Clinical Endocrinology & Diabetes. 108(2). 100–105. 80 indexed citations

Heinemann, Lutz, et al.. (1999). Time‐action profile of the soluble, fatty acid acylated, long‐acting insulin analogue NN304. Diabetic Medicine. 16(4). 332–338. 125 indexed citations

Kimmerle, Renate, Lutz Heinemann, Tim Heise, et al.. (1999). Influence of Continuous Combined Estradiol-Norethisterone Acetate Preparations on Insulin Sensitivity in Postmenopausal Nondiabetic Women. Menopause The Journal of The North American Menopause Society. 6(1). 36???42–36???42. 48 indexed citations

Rave, Klaus, Tim Heise, C. Weyer, et al.. (1998). Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects. Diabetic Medicine. 15(9). 747–751. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact